Drug Profile
TMC 2001
Alternative Names: TMC 001; TMC-2-001Latest Information Update: 06 Feb 2017
Price :
$50
*
At a glance
- Originator Targeted Molecules Corporation
- Class Neuroprotectants
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued CNS disorders; Thrombosis
Most Recent Events
- 06 Feb 2017 Discontinued - Preclinical for CNS disorders in USA (unspecified route)
- 06 Feb 2017 Discontinued - Preclinical for Thrombosis in USA (unspecified route)
- 08 Feb 2005 Suspended - Preclinical for CNS disorders in USA (unspecified route)